|
Alzheimer Disease
Citations 391-400 of 489 total displayed.
|
Past content
(since Jan 1998):
|
- Original Contributions
Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer Disease
- Ulrich Finckh; Heinz von der Kammer; Joachim Velden; Tiana Michel; Barbara Andresen; Amy Deng; Jun Zhang; Tomas Müller-Thomsen; Kathrin Zuchowski; Gunnar Menzer; Ulrike Mann; Andreas Papassotiropoulos; Reinhard Heun; Jan Zurdel; Frederik Holst; Luisa Benussi; Gabriela Stoppe; Jochen Reiss; André R. Miserez; Hannes B. Staehelin; G. William Rebeck; Bradley T. Hyman; Giuliano Binetti; Christoph Hock; John H. Growdon; Roger M. Nitsch
Arch Neurol 2000; 57: 1579-1583.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
- G. Anthony Broe; David A. Grayson; Helen M. Creasey; Louise M. Waite; Barney J. Casey; Hayley P. Bennett; William S. Brooks; Glenda M. Halliday
Arch Neurol 2000; 57: 1586-1591.
[Abstract]
[Full text]
[PDF]
- Editorials
Is There a Connection Between the Concentration of Cholesterol Circulating in Plasma and the Rate of Neuritic Plaque Formation in Alzheimer Disease?
- Robert W. Haley; John M. Dietschy
Arch Neurol 2000; 57: 1410-1412.
[Extract]
[Full text]
[PDF]
- Original Contributions
Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors
- Benjamin Wolozin; Wendy Kellman; Paul Ruosseau; Gastone G. Celesia; George Siegel
Arch Neurol 2000; 57: 1439-1443.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Novel Presenilin 1 Mutations Associated With Early Onset of Dementia in a Family With Both Early-Onset and Late-Onset Alzheimer Disease
- Gayatria Devi; Alexandra Fotiou; Darlene Jyrinji; Benjamin Tycko; Steve DeArmand; Ekaterina Rogaeva; You-Quiang Song; Helena Medieros; Yan Liang; Antonio Orlacchio; Jennifer Williamson; Peter St George-Hyslop; Richard Mayeux
Arch Neurol 2000; 57: 1454-1457.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Small Concomitant Vascular Lesions Do Not Influence Rates of Cognitive Decline in Patients With Alzheimer Disease
- Jae-Hong Lee; John M. Olichney; Lawrence A. Hansen; C. Richard Hofstetter; Leon J. Thal
Arch Neurol 2000; 57: 1474-1479.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
Antioxidant Therapy in Neurologic Disease
- Norman Delanty; Marc A. Dichter
Arch Neurol 2000; 57: 1265-1270.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Contribution of Lewy Body Inclusions to Dementia in Patients With and Without Alzheimer Disease Neuropathological Conditions
- Vahram Haroutunian; Michael Serby; Dushyant P. Purohit; Daniel P. Perl; Deborah Marin; Melinda Lantz; Richard C. Mohs; Kenneth L. Davis
Arch Neurol 2000; 57: 1145-1150.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Cytokine Gene Expression as a Function of the Clinical Progression of Alzheimer Disease Dementia
- James D. Luterman; Vahram Haroutunian; Shrishailam Yemul; Lap Ho; Dushyant Purohit; Paul S. Aisen; Richard Mohs; Giulio Maria Pasinetti
Arch Neurol 2000; 57: 1153-1160.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
 -Peptide Immunization: A Possible New Treatment for Alzheimer Disease
- Dale B. Schenk; Peter Seubert; Ivan Lieberburg; Jan Wallace
Arch Neurol 2000; 57: 934-936.
[Extract]
[Full text]
[PDF]
|
|
